Novo Nordisk (Ozempic)
Last year Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, overtook LVMH to become Europe’s most valuable company. And the pull for Acquired to finally tackle healthcare (18% of US GDP!) became too strong for us to resist. While we didn’t know much about Novo Nordisk before diving in, our…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like Acquired →
Trillion Dollar Shot, Episode 1: Birth of a Blockbuster
Here's How the New Weight Loss Drugs Could Change Everything
Novo Nordisk, Eli Lilly and the GLP-1 economy
Pfizer and Novo Nordisk’s $10bn battle over weight-loss drugs
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.